The National Institute for Health and Care Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Selective internal radiation therapy for primary hepatocellular carcinoma.

The committee agreed that two pieces of guidance would be produced following consideration of the overview for SIRT for primary hepatocellular carcinoma and primary cholangiocarcinoma. Please see NICE interventional procedure guidance 459.

Coding recommendations

J12.3 Selective internal radiotherapy with microspheres to lesion of liver

X65.3 Delivery of a fraction of interstitial radiotherapy

Y36.4 Introduction of non-removable radioactive substance into organ for brachytherapy NOC

Y89.- Brachytherapy

Y53.4 Approach to organ under fluoroscopic control

  • National Institute for Health and Care Excellence (NICE) accreditation logo